Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Cavernoma of the conus medullaris mimicking transverse myelitis.
Minocycline Hydrochloride (1818)
Functional plasticity in MS: Friend or foe?
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
Treatment of Acute Disseminated Encephalomyelitis.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Sleep and oligodendrocyte functions.
Rare Inflammatory Diseases of the White Matter and Mimics of Multiple Sclerosis and Related Disorders.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Management of optic neuritis as a clinically first event of multiple sclerosis.
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Natalizumab in clinical practice: managing the risks, enjoying the benefits.
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.
Alemtuzumab for multiple sclerosis: who and when to treat?
Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.

Pages